Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Precancerous Condition: early-phase trial registry
2 of 19 indexed Precancerous Condition trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 2 currently recruiting · #902 of 28,707 conditions by registered trial count
Precancerous Condition: 19 US clinical trials tracked, 2 recruiting.
Precancerous Condition is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 3 of these trials.
Enrollment posture brief
Registry condition precancerous-condition
OPEN 2 | RECR 11% | LATE 3 | EARLY 7 | RANK #902 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Vitamin D Deficiency (10% recruiting · 49 trials)
Precancerous Condition lists 2 open slots (11% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Precancerous Condition on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Precancerous Condition is recruiting below its size-band peers.
2 of 19 indexed trials (10.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Precancerous Condition research.
University of Colorado, Denver accounts for 3 of 19 trials (15.8%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Precancerous Condition enrolment sits around 152 participants.
Median target enrolment is 152 among the 16 trials that report a genuine target (sentinel values excluded). 7 of those (43.8%) plan for fewer than 100 participants.
-
Precancerous Condition splits between interventional and observational designs.
12 interventional and 7 observational studies make up this index (63.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Vanderbilt University Medical Center
NCT00899626
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
NCT00900419
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Radiation Therapy Oncology Group
NCT01302834
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer
Gynecologic Oncology Group
NCT00003384
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Mayo Clinic
NCT00661999
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
SWOG Cancer Research Network
NCT00900263
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
University of Alabama at Birmingham
NCT00703196
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
University of Colorado, Denver
NCT00084409
Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
University of Colorado, Denver
NCT00897364
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
Vanderbilt-Ingram Cancer Center
NCT00666211
Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
Children's Oncology Group
NCT00445718
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
AIDS Malignancy Consortium
NCT01946217
Lovastatin in Treating Patients At High Risk of Melanoma
National Cancer Institute (NCI)
NCT00462280
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
National Cancer Institute (NCI)
NCT00841204
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
City of Hope Medical Center
NCT00589563
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
OHSU Knight Cancer Institute
NCT00627276
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Boston Medical Center
NCT00006340
Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II
National Cancer Institute (NCI)
NCT00099112
PS-341 in Treating Patients With Advanced Cancer
Mayo Clinic
NCT00006362
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Precancerous Condition records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Precancerous Condition trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Precancerous Condition page
19 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Precancerous Condition trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Colorado, Denver sponsors the most Precancerous Condition trials on record, review their full trial history before evaluating a specific study. See University of Colorado, Denver's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Precancerous Condition condition card totals 19 registered trials; most-linked intervention placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.